Volatolomic approaches for improving success rates in assisted reproductive technology

MSCA (Marie Skłodowska-Curie)HORIZON-TMA-MSCA-SEID: 101131151
EC Contribution
€14,950
Consortium Size
8 orgs
Start Year
2023
Summary

Volatolomics has emerged as a new frontier in deciphering unreached matters related with health conditions. Volatolomics research is based on the study of the volatile compounds emitted by biological samples. It was demonstrated that the volatiles emitted though breath, skin, feces, urine or cells can provide useful information for the diagnosis of an important number of diseases, such as cancer, diabetes, or even neurodegenerative disorders. We have very recently demonstrated that the embryos do also emit volatiles during their development, while genetical disorders alter the pattern of the released volatiles. In the present project, we aim at assessing volatolomic techniques for the non-invasive assessment of embryos quality in order to select the most viable ones for transfer. The ultimate goal of this project is to achieve higher success rates in the in vitro fertilisation.

Consortium (8)

Project Results (4)

Source: CORDIS, the EU research results database.

Publications (1)
Analytica Chimica Acta
Analytica Chimica Acta· 2024DOI
Jhon Fiscal-Ladino, Juan Jose Lozada-Castro, Jhon Jairo Rios-Acevedo, Diego Montaño-Montoya, Eduardo Carasek, Pablo Richter, Alvaro Pulzara-Mora, Liliana Moncayo Martínez, Milton Rosero-Moreano,
Deliverables (2)
Data Management Plan
Websites, patent fillings, videos etc.
Other Results (1)
Periodic Reporting for period 1 - ARTVOC (Volatolomic approaches for improving success rates in assisted reproductive technology)